Stock Analysts’ updated eps estimates for Monday, August 5th:
ACV Auctions (NASDAQ:ACVA) had its outperform rating reissued by analysts at Barrington Research. The firm currently has a $23.00 target price on the stock.
Adaptimmune Therapeutics (NASDAQ:ADAP) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $4.00 target price on the stock.
Powerfleet (NASDAQ:AIOT) had its outperform rating reiterated by analysts at Barrington Research. Barrington Research currently has a $10.00 target price on the stock.
Arteris (NASDAQ:AIP) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $15.00 target price on the stock.
AMC Entertainment (NYSE:AMC) had its neutral rating reaffirmed by analysts at Wedbush. They currently have a $4.00 price target on the stock.
AMC Entertainment (NYSE:AMC) had its hold rating reiterated by analysts at Benchmark Co..
AON (NYSE:AON) had its sector perform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $335.00 target price on the stock.
Ares Capital (NASDAQ:ARCC) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $22.00 target price on the stock.
Arhaus (NASDAQ:ARHS) had its outperform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $18.00 price target on the stock.
Axonics (NASDAQ:AXNX) had its hold rating reaffirmed by analysts at Needham & Company LLC.
Axsome Therapeutics (NASDAQ:AXSM) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $130.00 target price on the stock.
BridgeBio Pharma (NASDAQ:BBIO) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $43.00 price target on the stock.
Brookfield Business Partners (NYSE:BBU) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $32.00 target price on the stock.
Brookfield Renewable Partners (NYSE:BEP) (TSE:BEP) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $31.00 price target on the stock.
Biogen (NASDAQ:BIIB) had its buy rating reissued by analysts at Truist Financial Co.. They currently have a $302.00 target price on the stock, down from their previous target price of $340.00.
Booking (NASDAQ:BKNG) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $3,900.00 target price on the stock.
BioMarin Pharmaceutical (NASDAQ:BMRN) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $110.00 price target on the stock.
Cars.com (NYSE:CARS) had its outperform rating reiterated by analysts at Barrington Research. Barrington Research currently has a $25.00 target price on the stock.
Cboe Global Markets (BATS:CBOE) had its overweight rating reiterated by analysts at Piper Sandler. The firm currently has a $210.00 target price on the stock, up from their previous target price of $203.00.
Cognex (NASDAQ:CGNX) had its equal weight rating reiterated by analysts at Stephens. They currently have a $45.00 price target on the stock.
Coherus BioSciences (NASDAQ:CHRS) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $12.00 price target on the stock.
Centene (NYSE:CNC) had its equal weight rating reissued by analysts at Stephens. They currently have a $78.00 target price on the stock.
Coinbase Global (NASDAQ:COIN) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $260.00 price target on the stock.
Costco Wholesale (NASDAQ:COST) had its outperform rating reissued by analysts at Telsey Advisory Group. They currently have a $925.00 target price on the stock.
Commercial Vehicle Group (NASDAQ:CVGI) had its outperform rating reiterated by analysts at Barrington Research. The firm currently has a $10.00 price target on the stock.
Casella Waste Systems (NASDAQ:CWST) had its buy rating reissued by analysts at Stifel Nicolaus. The firm currently has a $117.00 price target on the stock, up from their previous price target of $110.00.
DHI Group (NYSE:DHX) had its outperform rating reaffirmed by analysts at Barrington Research. They currently have a $7.00 price target on the stock.
DraftKings (NASDAQ:DKNG) had its buy rating reissued by analysts at Stifel Nicolaus. The firm currently has a $48.00 price target on the stock, down from their previous price target of $50.00.
DraftKings (NASDAQ:DKNG) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $60.00 price target on the stock.
Dun & Bradstreet (NYSE:DNB) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $17.00 price target on the stock.
Distribution Solutions Group (NASDAQ:DSGR) had its overweight rating reaffirmed by analysts at Stephens. Stephens currently has a $42.00 target price on the stock.
Enovix (NASDAQ:ENVX) had its overweight rating reissued by analysts at Piper Sandler. They currently have a $19.00 price target on the stock, down from their previous price target of $23.00.
FIGS (NYSE:FIGS) had its market perform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $6.00 target price on the stock.
FTAI Infrastructure (NASDAQ:FIP) had its market outperform rating reiterated by analysts at JMP Securities. The firm currently has a $12.00 target price on the stock.
Generac (NYSE:GNRC) had its overweight rating reissued by analysts at Stephens. Stephens currently has a $200.00 target price on the stock.
Green Plains (NASDAQ:GPRE) had its buy rating reaffirmed by analysts at Truist Financial Co.. They currently have a $25.00 price target on the stock, down from their previous price target of $30.00.
Gritstone bio (NASDAQ:GRTS) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $5.00 price target on the stock.
Gritstone bio (NASDAQ:GRTS) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $4.00 price target on the stock.
Global Ship Lease (NYSE:GSL) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a $29.00 target price on the stock.
Warrior Met Coal (NYSE:HCC) had its hold rating reissued by analysts at Benchmark Co..
Holley (NYSE:HLLY) had its buy rating reissued by analysts at Benchmark Co.. They currently have a $12.00 price target on the stock.
Helmerich & Payne (NYSE:HP) had its hold rating reaffirmed by analysts at Benchmark Co..
Integral Ad Science (NASDAQ:IAS) had its hold rating reaffirmed by analysts at Benchmark Co..
Installed Building Products (NYSE:IBP) had its equal weight rating reiterated by analysts at Stephens. They currently have a $240.00 price target on the stock.
Itron (NASDAQ:ITRI) had its equal weight rating reiterated by analysts at Stephens. The firm currently has a $110.00 price target on the stock.
Jasper Therapeutics (NASDAQ:JSPR) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $65.00 price target on the stock.
OPENLANE (NYSE:KAR) had its outperform rating reissued by analysts at Barrington Research. They currently have a $25.00 price target on the stock.
Koppers (NYSE:KOP) had its outperform rating reissued by analysts at Barrington Research. Barrington Research currently has a $64.00 target price on the stock.
Krystal Biotech (NASDAQ:KRYS) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $200.00 price target on the stock.
nLIGHT (NASDAQ:LASR) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $15.00 target price on the stock.
AEye (NASDAQ:LIDR) had its hold rating reiterated by analysts at Westpark Capital.
Eli Lilly and Company (NYSE:LLY) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $885.00 price target on the stock.
Liquidity Services (NASDAQ:LQDT) had its outperform rating reiterated by analysts at Barrington Research. The firm currently has a $27.00 price target on the stock.
MasTec (NYSE:MTZ) had its hold rating reissued by analysts at Truist Financial Co.. They currently have a $112.00 price target on the stock, up from their previous price target of $109.00.
Insight Enterprises (NASDAQ:NSIT) had its outperform rating reaffirmed by analysts at Barrington Research. The firm currently has a $225.00 target price on the stock.
NVIDIA (NASDAQ:NVDA) had its buy rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They currently have a $135.00 price target on the stock.
NVIDIA (NASDAQ:NVDA) had its hold rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a $100.00 price target on the stock.
Novo Nordisk A/S (NYSE:NVO) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $160.00 price target on the stock.
Paylocity (NASDAQ:PCTY) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $250.00 price target on the stock.
Power Integrations (NASDAQ:POWI) had its buy rating reaffirmed by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $95.00 target price on the stock, down from their previous target price of $100.00.
Proto Labs (NYSE:PRLB) had its hold rating reaffirmed by analysts at Needham & Company LLC.
Perella Weinberg Partners (NASDAQ:PWP) had its market outperform rating reaffirmed by analysts at JMP Securities. They currently have a $22.00 target price on the stock.
Quanta Services (NYSE:PWR) had its buy rating reissued by analysts at Truist Financial Co.. Truist Financial Co. currently has a $319.00 target price on the stock, up from their previous target price of $305.00.
Qualys (NASDAQ:QLYS) had its hold rating reaffirmed by analysts at Westpark Capital.
QuantumScape (NYSE:QS) had its hold rating reissued by analysts at Truist Financial Co.. They currently have a $7.00 price target on the stock, up from their previous price target of $6.00.
R1 RCM (NASDAQ:RCM) had its hold rating reiterated by analysts at TD Cowen. They currently have a $14.30 target price on the stock, down from their previous target price of $20.00.
Repligen (NASDAQ:RGEN) had its hold rating reissued by analysts at Benchmark Co..
RingCentral (NYSE:RNG) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $42.00 target price on the stock.
Surmodics (NASDAQ:SRDX) had its hold rating reaffirmed by analysts at Needham & Company LLC.
Stagwell (NASDAQ:STGW) had its buy rating reaffirmed by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $8.00 target price on the stock.
Trane Technologies (NYSE:TT) had its equal weight rating reiterated by analysts at Stephens. Stephens currently has a $350.00 target price on the stock.
Take-Two Interactive Software (NASDAQ:TTWO) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $190.00 target price on the stock.
Under Armour (NYSE:UAA) had its market perform rating reiterated by analysts at Telsey Advisory Group. They currently have a $7.00 target price on the stock.
Valaris (NYSE:VAL) had its buy rating reiterated by analysts at Benchmark Co.. Benchmark Co. currently has a $90.00 price target on the stock.
V.F. (NYSE:VFC) had its neutral rating reissued by analysts at Wedbush. They currently have a $13.00 price target on the stock.
Vertex Pharmaceuticals (NASDAQ:VRTX) had its buy rating reiterated by analysts at Truist Financial Co.. The firm currently has a $550.00 price target on the stock, up from their previous price target of $508.00.
WESCO International (NYSE:WCC) had its overweight rating reaffirmed by analysts at Stephens. The firm currently has a $190.00 price target on the stock.
Zillow Group (NASDAQ:ZG) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $60.00 price target on the stock.
Zoom Video Communications (NASDAQ:ZM) had its buy rating reaffirmed by analysts at Benchmark Co.. They currently have a $83.00 target price on the stock.
Zevra Therapeutics (NASDAQ:ZVRA) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald.
Receive News & Ratings for ACV Auctions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACV Auctions Inc and related companies with MarketBeat.com's FREE daily email newsletter.